Humoral and cellular response to SARS-CoV-2 mRNA vaccine in paediatric heart transplant recipients
HTR had humoral response after vaccination, although they showed lower levels of specific anti-S antibodies compared to HC. There were no significant differences in the SARS-CoV2-specific cellular response between the two groups. Obtaining satisfactory data on this type of response could potentially challenge the current vaccine guideline recommendations.
Authors
- Manuela Camino López
- Begoña Santiago (ORCID: https://orcid.org/0000-0002-4125-0423)
- Amanda Bermejo (ORCID: https://orcid.org/0000-0003-0109-0805)
- Roberto Alonso (ORCID: https://orcid.org/0000-0002-0516-6371)
- María Ángeles Muñoz‐Fernández (ORCID: https://orcid.org/0000-0002-0813-4500)
- Alicia Hernanz‐Lobo (ORCID: https://orcid.org/0000-0002-9560-9104)
- Laura Tarancón‐Díez
- Beatriz Lazaro-Martin (ORCID: https://orcid.org/0009-0001-8254-9085)
- Nuria Gil Villanueva
- María Luisa Navarro Gómez
Institutions
- Universidad Complutense de Madrid (ES)
- Instituto de Salud Carlos III (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
Publication Details
- Journal
- Heliyon
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e41584
- Citations
- 2
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.78
Funders
- European Society for Paediatric Infectious Diseases
- Ministerio de Ciencia e Innovación
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina
- Instituto de Investigación Sanitaria Gregorio Marañón
- Instituto de Salud Carlos III